CLINICAL_TRIALS
trial_result
· 2009-03-27
Clinical Trial Update: Atlantis Symbicort [Phase 3]
Summary
A Phase 3 trial of Atlantis Symbicort (budesonide/formoterol) for asthma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED